153 related articles for article (PubMed ID: 31300287)
1. Purification of rabies virus produced in Vero cells grown in serum free medium.
Trabelsi K; Ben Zakour M; Kallel H
Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
Rourou S; Ben Zakkour M; Kallel H
Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
[TBL] [Abstract][Full Text] [Related]
3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
4. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
5. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification.
Prem Kumar AA; Mani KR; Palaniappan C; Bhau LN; Swaminathan K
Microbes Infect; 2005 Jul; 7(9-10):1110-6. PubMed ID: 16046167
[TBL] [Abstract][Full Text] [Related]
6. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.
Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H
Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697
[TBL] [Abstract][Full Text] [Related]
7. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask.
Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A
Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056
[TBL] [Abstract][Full Text] [Related]
8. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
[TBL] [Abstract][Full Text] [Related]
9. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
[TBL] [Abstract][Full Text] [Related]
10. Higher production of rabies virus in serum-free medium cell cultures on microcarriers.
Frazzati-Gallina NM; Paoli RL; Mourão-Fuches RM; Jorge SA; Pereira CA
J Biotechnol; 2001 Dec; 92(1):67-72. PubMed ID: 11604174
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell].
Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837
[TBL] [Abstract][Full Text] [Related]
12. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
[TBL] [Abstract][Full Text] [Related]
13. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
[TBL] [Abstract][Full Text] [Related]
14. Preparation of human rabies vaccine in VERO cell culture using a microcarrier system.
Mendonça RZ; Ioshimoto LM; Mendonça RM; De-Franco M; Valentini EJ; Beçak W; Raw I; Pereira CA
Braz J Med Biol Res; 1993 Dec; 26(12):1305-17. PubMed ID: 8136732
[TBL] [Abstract][Full Text] [Related]
15. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.
Arifin MA; Mel M; Abdul Karim MI; Ideris A
J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497
[TBL] [Abstract][Full Text] [Related]
16. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use.
el-Karamany RM
Acta Virol; 1987 Aug; 31(4):321-8. PubMed ID: 2892381
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine.
Jones RL; Froeschle JE; Atmar RL; Matthews JS; Sanders R; Pardalos J; Moeller L; Chin JE; Famula M; Briggs DJ; Lang J
Vaccine; 2001 Sep; 19(32):4635-43. PubMed ID: 11535311
[TBL] [Abstract][Full Text] [Related]
18. Removing residual DNA from Vero-cell culture-derived human rabies vaccine by using nuclease.
Li SM; Bai FL; Xu WJ; Yang YB; An Y; Li TH; Yu YH; Li DS; Wang WF
Biologicals; 2014 Sep; 42(5):271-6. PubMed ID: 25108516
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
Kallel H; Jouini A; Majoul S; Rourou S
J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860
[TBL] [Abstract][Full Text] [Related]
20. Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium.
He C; Yang Z; Tong K
J Chromatogr A; 2011 Aug; 1218(31):5279-85. PubMed ID: 21726872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
